The Marble Center Announces the Winners of the 2023 Cancer Nanomedicine Poster Symposium
On May 9, 2023, the MIT community as well as members the Industry Affiliate program at the Marble Center in Nanomedicine (IAMNano) participated in a poster symposium organized by the Marble Center for Cancer Nanomedicine to discuss nano- and precision-based approaches for the early detection and treatment of a variety of diseases, including cancer. 20 research posters were selected for this event, representing 25 research investigators from various institutes and departments at MIT, the Koch Institute, the Broad Institute, Mass General Hospital, Dana–Farber/Harvard Cancer Center, the Ragon Institute, and Brigham and Women’s Hospital, among many others.
We are grateful for our wonderful panel of judges who helped us select this year’s winners: Drs. Richard Huang (Sanofi), Sadik Kassim (Danaher Corp.), Nicole Kogan (Alloy Therapeutics), Susumu Shimoyama (FUJIFILM Pharmaceuticals U.S.A.), Miao-Chih Tsai (Stanford), and Jane Wilkinson (MIT).
The winners of this year’s poster symposium are:
Patrick Han, PhD from the Galloway Lab for his poster on “Tuning proliferation and plasticity in transdifferentiation for scalable production of therapeutic cells.”
Rajith Manan, PhD from the Anderson Lab for his poster on “A combinatorial library of novel ionizable lipids for delivery of mRNA and CRISPR-Cas9 genome editing in the lungs.”
Anna Romanov from the Bathe and Irvine Labs for her poster on “A DNA-scaffolded vaccine platform for programmable presentation of HIV immunogens.”
Cathy Wang from the Bhatia Lab for her poster on “Engineering synthetic chemokines for dendritic cell recruitment to immune-cold tumors.”
Jacob Witten, PhD from the Anderson Lab for his poster on “Deep learning for lipid nanoparticle-based mRNA delivery.”
Winners of the 2023 Marble Center Poster Symposium. From left to right: Dr. Jacob Witten (Anderson Lab), Cathy Wang (Bhatia Lab), Dr. Rajith Manan (Anderson Lab), Dr. Patrick Han (Galloway Lab), and Anna Romanov (Bathe and Irvine Labs).
